PHARMA LITERATI

Pharma Literati is proud to be an associate of Amazon.in. Now all our readers can get the Amazon product links on our blogs.  The products would be selected by the pharma literati team and would be related to the pharmacy field only. In our en-devour to serve the pharma fraternity we are happy to promote knowledge based products from Amazon.in. Please visit the blog to know the interesting products. 

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Invention Application No Inventors Institute Microemulsion based transdermal drug delivery of tea tree oil 2750/DEL/2010A 1) Dr. Anupama Diwan 2) Dr.S. Sardana Hindu College of Pharmacy, Sonepat, Haryana. Novel nanoemulsion/self nanoemulsifying drug delivery system for enhanced oral bioavailability of muscle relaxant 3903/DEL/2012A 1) Sinha, Vivek Ranjan 2) Ghai, Damanjeet Panjab University A novel synergistic he

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Invention Application No Inventors Institute/University Device for inducing anxiety-disorder in laboratory animals 201611012613A 1) Prof.(Dr.) Milind Parle 2) Dr. Isha Dhamija   3) Neeraj Sethi Guru Jambheshwar University of Science and Technology Campus, Hisar Starch glutamate based fast dissolving formulations for immediate release and enhanced dissolution rate of active pharmaceutical ingredients 6914/CHE/2015A 1) Dr.R. Santhosh K

BBC reports that a new gene therapy base drug has been approved recently. Please see: http://www.bbc.com/news/science-environment-36400206 Regulators have given one of the world's largest drug companies approval to sell a new gene therapy. The treatment is for an illness called ADA-SCID which prevents babies from fighting off everyday infections. This is the  first approval for a genetic therapy  granted to a large multinational drug company, GSK. Commentators say the development marks the beginning of many more genetic medicines from so-called "Big Pharma". The condition is extremely rare and affects around two dozen babies each year. Approval of the gene therapy paves the way for the development of treatments for more widespread illnesses such as thalassemia and sickle cell disease. Hundreds of inherited disorders such as cystic fibrosis, muscular dystrophy and many types of blindness are caused by faulty genes. Hype: The aim of gene therapies is t

Dr. Hemchandra P. Tipnis, retired principal of Bombay College of Pharmacy (BCP) and Central Executive Council Member of Indian Pharmaceutical Association (IPA) passed away on May 23, 2016 after a cardiac arrest. Born on July 7, 1933, Dr. Tipnis completed his Masters and Doctorate from University of California School of Pharmacy and University of Nebraska respectively. He pioneered the initial bioavailability studies in human volunteers and his research papers formed the basis for amendments to Drugs & Cosmetics Act, with the ultimate inclusion of Schedule Y in the Act. Dr Tipnis was amongst the first to understand the importance of industry tie-ups in growth of academic institutes and sew-up partnerships between the pharma industry and BCP, a move that propelled BCP into the big league of pharmacy colleges not just in the country but internationally as well. Dr. Tipnis was active in the professional activities of IPA and was elected president of Indian Pharmaceutical C

Antibiotics May Cease To Work Due To Overuse; Performing Caesarean, Chemo Could Become Dangerous Urgent action is needed to control the use of antibiotics before they cease to work, leaving a number of major conditions untreatable and causing “terrible human and economic cost“, a major study has warned. Resistance to antibiotics is growing at such an alarming rate that they risk losing effectiveness entirely, meaning medical procedures such as caesarean sections, joint replacements and chemotherapy could soon become too dangerous to perform . Unless urgent action is taken, drug-resistant infections will kill 10 million people a year by 2050, the report's authors warn. Drug-resistant infections are thought to be growing due to over-use of medicine such as antibiotics and antifungus treatments to treat minor conditions like the common cold. With over-use, resistance to the drugs builds up meaning some conditions become incurable and so-called `superbugs' such as MRSA dev

India Today reports that, drug price regulator NPPA has fixed the ceiling price of 27 drug formulation packs, including those used for the treatment of bacterial infections, diabetes, epilepsy among others. See: http://indiatoday.intoday.in/story/nppa-fixes-price-of-27-drug-formulation-packs/1/672654.html Besides, the drug price regulator has also fixed the retail price of four formulations. "NPPA has fixed/revised ceiling prices of 27 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of four formulations under DPCO, 2013," the National Pharmaceutical Pricing Authority (NPPA) said in a statement. Earlier this month, the NPPA had fixed ceiling price of 54 drug formulations used for treatment of cancer, diabetes rheumatoid arthritis, bacterial infections and hypertension. At present, the government fixes the prices of essential drugs based on the simple average of all medicines in a particular therapeu

This post is from our cousin-blog PharmaSastra in Nepal. A really passionate, young, vibrant team is working on the blog for Nepalese community and pharma industry.  Please visit:  http://pharmasastra.blogspot.in/ These days in many parts of the world, people are tattooing their body with various inks. Its has been seen that even in the major cities of Nepal, this culture is increasing surprisingly. The main question here arise is "Is tattoo safe for our body?" As the tattoo is the way of imprinting the pigments below our dermal layer.  As the ink is exposed to our body, are we conscious about it? Is the concerned body really concerned about our health? What the TATTOO ink contains? As per the  FDA is analyzing tattoo inks and pigments for contaminants, heavy metals, degradants, potentially toxic chemicals—including pH stabilizers, microbicides and coating agents—and other materials that are not intended to be placed into the body.   Its has been reported i

Source:  http://www.bbc.com/news/health-36321394 A global revolution in the use of antimicrobials is needed, according to a government backed report. Lord Jim O'Neill, who led the Review on Antimicrobial Resistance, said a campaign was needed to stop people treating antibiotics like sweets. It is the first recommendation in the global plan for preventing medicine "being cast back into the dark ages". The report has received a mixed response with some concerned that it does not go far enough. Superbugs, resistant to antimicrobials, are estimated to account for 700,000 deaths each year. But modeling up to the year 2050, by Rand Europe and auditors KPMG, suggests 10 million people could die each year - equivalent to one every three seconds. The report brings together eight previous interim reports that recommended: §   An urgent and massive global awareness campaign as most people are ignorant of the risks §   Establishing a $2bn ($1.4bn) Global